GI
VRTX icon

GAMMA Investing’s Vertex Pharmaceuticals VRTX Stock Holding History

GAMMA Investing’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.96M Buy
7,569
+651
+9% +$333K 0.13% 118
2026
Q2 		$3.44M Buy
6,918
+326
+5% +$144K 0.13% 128
2026
Q1 		$2.94M Buy
6,592
+878
+15% +$409K 0.14% 120
2025
Q4 		$2.59M Buy
5,714
+1,082
+23% +$466K 0.13% 124
2025
Q3 		$1.81M Sell
4,632
-80
-2% -$33.4K 0.1% 171
2025
Q2 		$2.1M Sell
4,712
-290
-6% -$134K 0.13% 127
2025
Q1 		$2.43M Buy
5,002
+1,005
+25% +$468K 0.18% 93
2024
Q4 		$1.61M Buy
3,997
+87
+2% +$40.3K 0.14% 128
2024
Q3 		$1.82M Buy
3,910
+909
+30% +$437K 0.18% 105
2024
Q2 		$1.41M Buy
3,001
+833
+38% +$362K 0.19% 92
2024
Q1 		$906K Buy
2,168
+163
+8% +$68.9K 0.18% 93
2023
Q4 		$869K Buy
+2,005
New +$741K 0.24% 67

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAMMA Investing's VRTX Position: Q3 2026 in Review

GAMMA Investing increased its Vertex Pharmaceuticals (VRTX) stake by 9.4% in Q3 2026, buying an estimated $333K and bringing the position to 7,569 shares worth $3.96M. The position accounts for 0.13% of the portfolio, ranked #118.

GAMMA Investing first reported a position in VRTX in Q4 2023 and has held it in 12 quarters since. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • GAMMA Investing held 7,569 shares of Vertex Pharmaceuticals worth $3.96M as of Q3 2026.
  • GAMMA Investing bought 651 Vertex Pharmaceuticals shares in Q3 2026, an estimated $333K.
  • Vertex Pharmaceuticals made up 0.13% of GAMMA Investing's portfolio in Q3 2026, its #118 holding.
  • GAMMA Investing first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.